Research News

21 July 2025

Gene essential for vitamin D absorption could help unlock treatments for cancer and autoimmune diseases

Vitamin D is not only an essential nutrient, but also the precursor of the hormone calcitriol, indispensable for health: it regulates the uptake of phosphate and calcium necessary for bones by the intestines, as well as cell growth and the proper function of muscles, nerve cells, and the immune system.
21 July 2025

Common sugar substitute shown to impair brain cells, boost stroke risk

From low-carb ice cream to keto protein bars to “sugar-free” soda, the decades-old sweetener erythritol is everywhere. But new University of Colorado Boulder research shows the popular sugar substitute and specialty food additive comes with serious downsides, impacting brain cells in numerous ways that can boost risk of stroke.
19 July 2025

Semaglutide and Tirzepatide linked to lower dementia and stroke risk, study finds

A new study published in JAMA Network Open offers promising insights for clinicians and researchers working in diabetes, obesity, and neurodegenerative care.
17 July 2025

One drug offers hope for stroke patients

Stroke is said to be the second leading cause of death worldwide after heart disease. To prevent the death of neurons in the brain, a research group led by Osaka Metropolitan University Associate Professor Hidemitsu Nakajima of the Graduate School of Veterinary Science has developed a drug that inhibits a protein involved in cell death.
16 July 2025

Breakthrough in Antibiotic Production : Scientists Unlock Genes to Mass-Produce Monensin

In a significant step forward for industrial biotechnology, researchers have successfully engineered a bacterial strain capable of producing record-breaking levels of monensin, a widely used antibiotic in veterinary medicine and agriculture.
16 July 2025

Mouse study finds tirzepatide slowed obesity-associated breast cancer growth

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast cancer growth in a mouse model, according to a study being presented Saturday at ENDO 2025, the Endocrine Society’s annual meeting in San Francisco, Calif.
9 July 2025

Novartis receives landmark approval for First Malaria Drug for newborns and young infants

In a major breakthrough for global child health, Novartis has received approval from Swissmedic for Coartem Baby, the worlds first malaria treatment specifically developed for newborns and young infants.
8 July 2025

Heart‑Disease Deaths Worldwide Linked to Common Plastic Chemical

A comprehensive global analysis by NYU Langone Health has identified a startling association between daily exposure to the plastic additive di‑2‑ethylhexyl phthalate (DEHP) and hundreds of thousands of heart‐related deaths.
8 July 2025

Cough Suppressant Ambroxol Found Safe but Ineffective on Cognitive Improvement in Parkinson’s Dementia

London, Ontario — A 52-week randomized, double-blind, placebo-controlled phase 2 trial has found that high-dose ambroxol, a common cough medicine repurposed as a molecular chaperone, is safe and achieves biochemical target engagement in Parkinson disease dementia (PDD), but shows no measurable cognitive benefits compared to placebo.
7 July 2025

Extensive Research confirms : COVID-19 vaccines not linked to sudden deaths among young adults

The Ministry of Health and Family Welfare released the findings of two significant studies by the Indian Council of Medical Research (ICMR), National Centre for Disease Control (NCDC), and All India Institute of Medical Sciences (AIIMS).